NLRP3 and oropharynx cancer: Although the clinical characteristics and prognosis of HPV-positive and HPV-negative oropharyngeal cancer are quite different (26), the expression levels of NLRP3 did not show differences in human oropharyngeal SCC specimens, regardless of whether they contained HPV DNA (27).